Atrial Fibrillation Patient Kit | Abbott
CARDIOVASCULAR
hamburger
BACK

Atrial fibrillation (AFib) is the most common type of heart arrhythmia.1 It affects 38 million people worldwide,2 and that number is expected to double by 2050.3

Patient education has been shown to improve treatment adherence, satisfaction and clinical outcomes.4 As AFib cases continue to rise, healthcare professionals can improve patient management with increased education.

AFib Patient Education Kit

This AFib and Ablation patient education kit contains content for your website, social media, and emails that can be shared with your patients to help educate them about AFib, ablation, and more. It includes our award-winning animations.

Download
Coverpage of the Atrial Fibrillation and Ablation Patient Education Kit PDF

AFib Patient Education Website

Share www.AFAnswers.com with your patients. It features patient-focused content about AFib and its treatment options, like cardiac ablation.

Visit
An older black man and a young black kid smiling happily

References

  1. Chugh SS, Haymoeller R, NarayananK et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study. Circ. 2014; 129:837-847.
  2. Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke. 2021 Feb;16(2):217-221. doi: 10.1177/1747493019897870. Epub 2020 Jan 19. Erratum in: Int J Stroke. 2020 Jan 28;:1747493020905964. PMID: 31955707.
  3. Go A, Hylek E, Phillips K, Chang Y, et al. Prevalence of Diagnosed Atrial Fibrillation in Adults: National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285(18): 2370-5. https://jamanetwork.com/journals/jama/fullarticle/193807
  4. Timmers, T., Janssen, L., Kool, R.B., and Kremer, J.A.M. (2020). Educating Patients by Providing Timely Information Using Smartphone and Tablet Apps: Systematic Review. Journal of Medical Internet Research, 22(4). https://doi.org/10.2196/17342

MAT-2116121 v2.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

YESNO
accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

YESNO
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

YESNO
accessibility

Precautions


Please be sure to read it.

The following pages are intended for medical professionals and provide information on the proper use of products (medical devices, etc.) of Abbott Medical Japan GK.

The information provided here is not intended to provide information to patients and the general public.



Are you a healthcare professional?

 

Test

yesno